Ozark Health Ventures, LLC dba Cancer Research for the Ozarks

描述（由申请人提供）：20多年来，Ozarks癌症研究（CRO）为密苏里州西南部和周边地区的农村社区提供了NCI批准的临床试验。通过有远见的领导医生，如温德尔古德温，医学博士和罗伯特L。医学博士，否则无法获得临床试验的患者可以选择通过社区临床肿瘤学计划参与。 从一开始，CRO就得到了两个国家认可的医疗保健系统的支持，考克斯健康和圣约翰卫生系统在斯普林菲尔德，密苏里州。随着两家乔普林附属公司的加入，CRO现在提供该地区95%以上的癌症护理资源，包括肿瘤学家，放射肿瘤学家，妇科肿瘤学家，泌尿科医生，外科医生和初级保健专家的医生网络。 CRO支持CCOP的使命，即通过增加试验应计费用来加速开发预防和治疗癌症的干预措施。在过去五年中，CRO的患者参与率超过5%，每年有200多名患者参加治疗和预防控制试验。CRO的33名医生研究人员积极参与该项目，提高了对治疗、控制和预防方面最新发展以及社区整体护理质量的认识。癌症研究组织还成功地增加了少数群体的参与，他们的入学比例高于一般癌症人口。

DESCRIPTION (provided by applicant): For over 20 years, Cancer Research for the Ozarks (CRO) has provided NCI-approved clinical trials to the rural communities of Southwestern Missouri and surrounding areas. Through the visionary leadership of physicians such as Wendall Goodwin, MD and Robert L. Carolla, MD, patients who otherwise would not have access to clinical trials can elect to participate through the Community Clinical Oncology Program. From its inception, CRO has had the support of the two nationally recognized health care systems, Cox Health and St. John's Health System in Springfield, Missouri. With the later addition of two Joplin affiliates, CRO now provides more than 95 percent of cancer care resources in the area including a physician network of oncologists, radiation oncologists, gynecological oncologists, urologists, surgeons, and primary care specialists. CRO supports the CCOP mission of accelerating development of interventions to prevent and treat cancer by increasing accruals to trials. CRO exceeds five percent patient participation with over 200 patients enrolled to treatment and prevention and control trials each of the past five years. CRO's thirty-three physician investigators actively participate in the program increasing awareness of recent developments in treatment, control and prevention and the overall quality of care in the community. CRO has also successfully increased involvement of minorities enrolling a higher percentage than that of the general cancer population.